Jiangsu Apon Medical Technology Co Ltd Class A (300753) — Cash Flow-to-Debt Ratio
Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of CN¥-2.69 Million could theoretically repay 0% of its total liabilities (CN¥153.56 Million) in one year. See Jiangsu Apon Medical Technology Co Ltd C free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Apon Medical Technology Co Ltd Class A Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Jiangsu Apon Medical Technology Co Ltd Class A across 11 annual periods. Also explore 300753 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
Year-by-year debt coverage analysis for Jiangsu Apon Medical Technology Co Ltd Class A. For market capitalisation and broader financial context, see Jiangsu Apon Medical Technology Co Ltd C stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥15.68 Million | CN¥155.62 Million | ▲ +170.1% |
| 2023 | -0.14x | CN¥-23.34 Million | CN¥162.38 Million | ▼ -7.4% |
| 2022 | -0.13x | CN¥-24.59 Million | CN¥183.85 Million | ▼ -186.7% |
| 2021 | 0.15x | CN¥18.29 Million | CN¥118.54 Million | ▼ -83.8% |
| 2020 | 0.95x | CN¥83.34 Million | CN¥87.40 Million | ▲ +1.7% |
| 2019 | 0.94x | CN¥77.59 Million | CN¥82.76 Million | ▼ -10.5% |
| 2018 | 1.05x | CN¥78.13 Million | CN¥74.56 Million | ▼ -15.8% |
| 2017 | 1.25x | CN¥67.08 Million | CN¥53.87 Million | ▲ +32.6% |
| 2016 | 0.94x | CN¥60.97 Million | CN¥64.92 Million | ▼ -14.0% |
| 2015 | 1.09x | CN¥38.08 Million | CN¥34.88 Million | ▲ +12.2% |
| 2014 | 0.97x | CN¥33.49 Million | CN¥34.43 Million | — |